Cargando…
A latent cardiomyocyte regeneration potential in human heart disease
Cardiomyocytes in the adult human heart show a regenerative capacity, with an annual renewal rate around 0.5%. Whether this regenerative capacity of human cardiomyocytes is employed in heart failure has been controversial. Using retrospective (14)C birth dating we analyzed cardiomyocyte renewal in p...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515906/ https://www.ncbi.nlm.nih.gov/pubmed/37745322 http://dx.doi.org/10.1101/2023.09.14.557681 |
_version_ | 1785109041990598656 |
---|---|
author | Derks, Wouter Rode, Julian Collin, Sofia Rost, Fabian Heinke, Paula Hariharan, Anjana Pickel, Lauren Simonova, Irina Lázár, Enikő Graham, Evan Jashari, Ramadan Andrä, Michaela Jeppsson, Anders Salehpour, Mehran Alkass, Kanar Druid, Henrik Kyriakopoulos, Christos P. Taleb, Iosif Shankar, Thirupura S. Selzman, Craig H. Sadek, Hesham Jovinge, Stefan Brusch, Lutz Frisén, Jonas Drakos, Stavros Bergmann, Olaf |
author_facet | Derks, Wouter Rode, Julian Collin, Sofia Rost, Fabian Heinke, Paula Hariharan, Anjana Pickel, Lauren Simonova, Irina Lázár, Enikő Graham, Evan Jashari, Ramadan Andrä, Michaela Jeppsson, Anders Salehpour, Mehran Alkass, Kanar Druid, Henrik Kyriakopoulos, Christos P. Taleb, Iosif Shankar, Thirupura S. Selzman, Craig H. Sadek, Hesham Jovinge, Stefan Brusch, Lutz Frisén, Jonas Drakos, Stavros Bergmann, Olaf |
author_sort | Derks, Wouter |
collection | PubMed |
description | Cardiomyocytes in the adult human heart show a regenerative capacity, with an annual renewal rate around 0.5%. Whether this regenerative capacity of human cardiomyocytes is employed in heart failure has been controversial. Using retrospective (14)C birth dating we analyzed cardiomyocyte renewal in patients with end-stage heart failure. We show that cardiomyocyte generation is minimal in end-stage heart failure patients at rates 18–50 times lower compared to the healthy heart. However, patients receiving left ventricle support device therapy, who showed significant functional and structural cardiac improvement, had a >6-fold increase in cardiomyocyte renewal relative to the healthy heart. Our findings reveal a substantial cardiomyocyte regeneration potential in human heart disease, which could be exploited therapeutically. |
format | Online Article Text |
id | pubmed-10515906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-105159062023-09-23 A latent cardiomyocyte regeneration potential in human heart disease Derks, Wouter Rode, Julian Collin, Sofia Rost, Fabian Heinke, Paula Hariharan, Anjana Pickel, Lauren Simonova, Irina Lázár, Enikő Graham, Evan Jashari, Ramadan Andrä, Michaela Jeppsson, Anders Salehpour, Mehran Alkass, Kanar Druid, Henrik Kyriakopoulos, Christos P. Taleb, Iosif Shankar, Thirupura S. Selzman, Craig H. Sadek, Hesham Jovinge, Stefan Brusch, Lutz Frisén, Jonas Drakos, Stavros Bergmann, Olaf bioRxiv Article Cardiomyocytes in the adult human heart show a regenerative capacity, with an annual renewal rate around 0.5%. Whether this regenerative capacity of human cardiomyocytes is employed in heart failure has been controversial. Using retrospective (14)C birth dating we analyzed cardiomyocyte renewal in patients with end-stage heart failure. We show that cardiomyocyte generation is minimal in end-stage heart failure patients at rates 18–50 times lower compared to the healthy heart. However, patients receiving left ventricle support device therapy, who showed significant functional and structural cardiac improvement, had a >6-fold increase in cardiomyocyte renewal relative to the healthy heart. Our findings reveal a substantial cardiomyocyte regeneration potential in human heart disease, which could be exploited therapeutically. Cold Spring Harbor Laboratory 2023-09-17 /pmc/articles/PMC10515906/ /pubmed/37745322 http://dx.doi.org/10.1101/2023.09.14.557681 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Derks, Wouter Rode, Julian Collin, Sofia Rost, Fabian Heinke, Paula Hariharan, Anjana Pickel, Lauren Simonova, Irina Lázár, Enikő Graham, Evan Jashari, Ramadan Andrä, Michaela Jeppsson, Anders Salehpour, Mehran Alkass, Kanar Druid, Henrik Kyriakopoulos, Christos P. Taleb, Iosif Shankar, Thirupura S. Selzman, Craig H. Sadek, Hesham Jovinge, Stefan Brusch, Lutz Frisén, Jonas Drakos, Stavros Bergmann, Olaf A latent cardiomyocyte regeneration potential in human heart disease |
title | A latent cardiomyocyte regeneration potential in human heart disease |
title_full | A latent cardiomyocyte regeneration potential in human heart disease |
title_fullStr | A latent cardiomyocyte regeneration potential in human heart disease |
title_full_unstemmed | A latent cardiomyocyte regeneration potential in human heart disease |
title_short | A latent cardiomyocyte regeneration potential in human heart disease |
title_sort | latent cardiomyocyte regeneration potential in human heart disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515906/ https://www.ncbi.nlm.nih.gov/pubmed/37745322 http://dx.doi.org/10.1101/2023.09.14.557681 |
work_keys_str_mv | AT derkswouter alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT rodejulian alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT collinsofia alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT rostfabian alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT heinkepaula alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT hariharananjana alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT pickellauren alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT simonovairina alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT lazareniko alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT grahamevan alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT jashariramadan alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT andramichaela alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT jeppssonanders alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT salehpourmehran alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT alkasskanar alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT druidhenrik alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT kyriakopouloschristosp alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT talebiosif alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT shankarthirupuras alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT selzmancraigh alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT sadekhesham alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT jovingestefan alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT bruschlutz alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT frisenjonas alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT drakosstavros alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT bergmannolaf alatentcardiomyocyteregenerationpotentialinhumanheartdisease AT derkswouter latentcardiomyocyteregenerationpotentialinhumanheartdisease AT rodejulian latentcardiomyocyteregenerationpotentialinhumanheartdisease AT collinsofia latentcardiomyocyteregenerationpotentialinhumanheartdisease AT rostfabian latentcardiomyocyteregenerationpotentialinhumanheartdisease AT heinkepaula latentcardiomyocyteregenerationpotentialinhumanheartdisease AT hariharananjana latentcardiomyocyteregenerationpotentialinhumanheartdisease AT pickellauren latentcardiomyocyteregenerationpotentialinhumanheartdisease AT simonovairina latentcardiomyocyteregenerationpotentialinhumanheartdisease AT lazareniko latentcardiomyocyteregenerationpotentialinhumanheartdisease AT grahamevan latentcardiomyocyteregenerationpotentialinhumanheartdisease AT jashariramadan latentcardiomyocyteregenerationpotentialinhumanheartdisease AT andramichaela latentcardiomyocyteregenerationpotentialinhumanheartdisease AT jeppssonanders latentcardiomyocyteregenerationpotentialinhumanheartdisease AT salehpourmehran latentcardiomyocyteregenerationpotentialinhumanheartdisease AT alkasskanar latentcardiomyocyteregenerationpotentialinhumanheartdisease AT druidhenrik latentcardiomyocyteregenerationpotentialinhumanheartdisease AT kyriakopouloschristosp latentcardiomyocyteregenerationpotentialinhumanheartdisease AT talebiosif latentcardiomyocyteregenerationpotentialinhumanheartdisease AT shankarthirupuras latentcardiomyocyteregenerationpotentialinhumanheartdisease AT selzmancraigh latentcardiomyocyteregenerationpotentialinhumanheartdisease AT sadekhesham latentcardiomyocyteregenerationpotentialinhumanheartdisease AT jovingestefan latentcardiomyocyteregenerationpotentialinhumanheartdisease AT bruschlutz latentcardiomyocyteregenerationpotentialinhumanheartdisease AT frisenjonas latentcardiomyocyteregenerationpotentialinhumanheartdisease AT drakosstavros latentcardiomyocyteregenerationpotentialinhumanheartdisease AT bergmannolaf latentcardiomyocyteregenerationpotentialinhumanheartdisease |